Table II.
Correlation between SOX2 expression and clinicopathological factors in patients with non-small cell lung carcinoma [case (%)].
| Variables | Case | SOX2 low expression | SOX2 high expression | P-value |
|---|---|---|---|---|
| Gender | ||||
| Male | 101 | 61 (74.4) | 40 (88.9) | 0.066 |
| Female | 26 | 21 (25.6) | 5 (11.1) | |
| Age | ||||
| ≥57 years | 66 | 40 (48.8) | 26 (57.8) | 0.358 |
| <57 years | 61 | 42 (51.2) | 19 (42.2) | |
| Smoking history | ||||
| Yes | 56 | 32 (39.0) | 24 (53.3) | 0.138 |
| No | 71 | 50 (61.0) | 21 (46.7) | |
| Pathological type | ||||
| Adenocarcinoma | 59 | 47 (57.3) | 12 (26.7) | 0.004 |
| Squamous carcinoma | 50 | 25 (30.5) | 25 (55.6) | |
| Adenosquamous carcinoma | 18 | 10 (12.2) | 8 (17.8) | |
| T staging | ||||
| T1 | 8 | 4 (4.9) | 4 (8.9) | 0.273 |
| T2 | 90 | 62 (75.6) | 28 (62.2) | |
| T3 | 29 | 16 (19.5) | 13 (28.9) | |
| N staging | ||||
| N0 | 47 | 31 (37.8) | 16 (35.6) | 0.403 |
| N1 | 31 | 17 (20.7) | 14 (31.1) | |
| N2 | 49 | 34 (41.5) | 15 (33.3) | |
| TNM staging | ||||
| I | 38 | 26 (31.7) | 12 (26.7) | 0.570 |
| II | 30 | 17 (20.7) | 13 (28.9) | |
| III | 59 | 39 (47.6) | 20 (44.4) |